Kathleen Medora / aacr - Patients with very large intrahepatic cholangiocarcinoma experienced improved outcomes when targeted, high-dose radiation was added to chemotherapy PHILADELPHIA – Patients with supermassive intrahepatic cholangiocarcinoma (ICC) benefited from ablative rad…
AI Summary: New clinical reports indicate that targeted high‑dose radiation can improve outcomes for very large “supermassive” bile duct tumors, offering better local control and symptom relief than conventional approaches. Early data suggest this intensity‑modulated strategy may expand options for otherwise difficult‑to‑treat cases, though longer follow‑up is needed to confirm survival benefits.
Small study reports 100% one‑year survival after lung transplant / 7 wks
ASTRO issues 2026 radiation guideline update for pancreatic cancer / 14 days
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 3 months
ESMO issues new metastatic colorectal cancer clinical guideline / 4 months
ASCO names 2027 FASCO fellows, honoring oncology leaders / 4 wks
SBRT extends progression‑free survival in oligometastatic breast cancer / 3 months
Perioperative advances reshape muscle‑invasive bladder cancer care / 5 wks
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.